Chemical Perturbation of Oncogenic Protein Folding: from the Prediction of Locally Unstable Structures to the Design of Disruptors of Hsp90-Client Interactions.


Journal

Chemistry (Weinheim an der Bergstrasse, Germany)
ISSN: 1521-3765
Titre abrégé: Chemistry
Pays: Germany
ID NLM: 9513783

Informations de publication

Date de publication:
03 Aug 2020
Historique:
received: 05 02 2020
pubmed: 14 3 2020
medline: 27 10 2020
entrez: 14 3 2020
Statut: ppublish

Résumé

Protein folding quality control in cells requires the activity of a class of proteins known as molecular chaperones. Heat shock protein-90 (Hsp90), a multidomain ATP driven molecular machine, is a prime representative of this family of proteins. Interactions between Hsp90, its co-chaperones, and client proteins have been shown to be important in facilitating the correct folding and activation of clients. Hsp90 levels and functions are elevated in tumor cells. Here, we computationally predict the regions on the native structures of clients c-Abl, c-Src, Cdk4, B-Raf and Glucocorticoid Receptor, that have the highest probability of undergoing local unfolding, despite being ordered in their native structures. Such regions represent potential ideal interaction points with the Hsp90-system. We synthesize mimics spanning these regions and confirm their interaction with partners of the Hsp90 complex (Hsp90, Cdc37 and Aha1) by Nuclear Magnetic Resonance (NMR). Designed mimics selectively disrupt the association of their respective clients with the Hsp90 machinery, leaving unrelated clients unperturbed and causing apoptosis in cancer cells. Overall, selective targeting of Hsp90 protein-protein interactions is achieved without causing indiscriminate degradation of all clients, setting the stage for the development of therapeutics based on specific chaperone:client perturbation.

Identifiants

pubmed: 32167602
doi: 10.1002/chem.202000615
pmc: PMC7415569
mid: NIHMS1576729
doi:

Substances chimiques

Carcinogens 0
Cell Cycle Proteins 0
HSP90 Heat-Shock Proteins 0
Molecular Chaperones 0
Chaperonins EC 3.6.1.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9459-9465

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM124256
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM139584
Pays : United States
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG 20019
Organisme : NIH HHS
ID : R01GM124256
Pays : United States

Informations de copyright

© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Références

Nat Rev Mol Cell Biol. 2017 Jun;18(6):345-360
pubmed: 28429788
Q Rev Biophys. 2011 May;44(2):229-55
pubmed: 21414251
Biomed J. 2013 May-Jun;36(3):106-17
pubmed: 23806880
Front Bioeng Biotechnol. 2015 Aug 24;3:119
pubmed: 26380257
Mol Cell. 2016 Apr 21;62(2):260-271
pubmed: 27105117
Biopolymers. 2010 Mar;93(3):211-7
pubmed: 19697319
J Am Chem Soc. 2003 Jun 25;125(25):7696-703
pubmed: 12812511
Oncotarget. 2016 Jan 26;7(4):3658-61
pubmed: 26820296
ACS Chem Biol. 2018 Aug 17;13(8):2288-2299
pubmed: 29893552
Nat Rev Cancer. 2010 Aug;10(8):537-49
pubmed: 20651736
Nat Struct Mol Biol. 2009 Mar;16(3):287-93
pubmed: 19234467
Cell. 2012 Aug 31;150(5):987-1001
pubmed: 22939624
Cell Rep. 2015 Aug 11;12(6):1006-18
pubmed: 26235616
J Chem Theory Comput. 2018 Nov 13;14(11):5992-6001
pubmed: 30281309
Elife. 2014 Dec 22;3:
pubmed: 25531069
Cell. 2006 Oct 20;127(2):329-40
pubmed: 17055434
Trends Cell Biol. 2007 Feb;17(2):87-92
pubmed: 17184992
Sci STKE. 2007 May 08;2007(385):pe22
pubmed: 17488976
Science. 2016 Jun 24;352(6293):1542-7
pubmed: 27339980
Cell. 2006 Oct 20;127(2):251-3
pubmed: 17055424
J Biol Chem. 2004 Sep 17;279(38):39975-81
pubmed: 15258137
Curr Top Med Chem. 2016;16(25):2727-8
pubmed: 27549859
Elife. 2017 Jul 25;6:
pubmed: 28742020
J Chem Theory Comput. 2018 Feb 13;14(2):1059-1070
pubmed: 29262682
Chem Biol. 2004 Jun;11(6):787-97
pubmed: 15217612
Cell Stress Chaperones. 2018 Jul;23(4):467-482
pubmed: 29392504
Trends Biochem Sci. 2013 May;38(5):253-62
pubmed: 23507089
Mol Cell. 2012 Aug 10;47(3):434-43
pubmed: 22727666
Comb Chem High Throughput Screen. 2002 Dec;5(8):605-11
pubmed: 12470257
Mol Cell. 2013 Feb 7;49(3):464-73
pubmed: 23260660
J Biol Chem. 2006 May 19;281(20):14361-9
pubmed: 16551624
J Biol Chem. 2001 Sep 7;276(36):33689-96
pubmed: 11441008
Cell. 2014 Jun 19;157(7):1685-97
pubmed: 24949977
Nat Struct Mol Biol. 2016 Nov;23(11):1020-1028
pubmed: 27723736
Clin Cancer Res. 2014 Jan 15;20(2):275-7
pubmed: 24166908
Biophys J. 2010 May 19;98(9):1966-75
pubmed: 20441761
ACS Chem Biol. 2012 Aug 17;7(8):1311-20
pubmed: 22725693
Biochemistry. 2003 Nov 4;42(43):12550-61
pubmed: 14580201
J Phys Chem Lett. 2019 Apr 4;10(7):1489-1497
pubmed: 30855965
ACS Chem Biol. 2013 Feb 15;8(2):397-404
pubmed: 23138758
Nat Struct Mol Biol. 2011 Jan;18(1):61-6
pubmed: 21170051
Mol Cell. 2014 Jan 23;53(2):330-43
pubmed: 24462206
Acc Chem Res. 2017 Mar 21;50(3):584-589
pubmed: 28945413
Trends Biochem Sci. 2017 Oct;42(10):799-811
pubmed: 28784328
Cell Chem Biol. 2016 Jan 21;23(1):158-172
pubmed: 26933742
Nat Rev Mol Cell Biol. 2010 Jul;11(7):515-28
pubmed: 20531426
Lancet Oncol. 2013 Aug;14(9):e358-69
pubmed: 23896275
Cancer Treat Rev. 2013 Jun;39(4):375-87
pubmed: 23199899
Proteins. 2008 Aug;72(2):660-72
pubmed: 18247351
Mol Cancer Res. 2015 Nov;13(11):1445-51
pubmed: 26219697

Auteurs

Antonella Paladino (A)

SCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.

Mark R Woodford (MR)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Sarah J Backe (SJ)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Rebecca A Sager (RA)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
College of Medicine, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Priyanka Kancherla (P)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Michael A Daneshvar (MA)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Victor Z Chen (VZ)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Dimitra Bourboulia (D)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Elham F Ahanin (EF)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Chrisostomos Prodromou (C)

Genome Damage and Stability Centre, University of Sussex, Brighton, BN1 9RQ, UK.

Greta Bergamaschi (G)

SCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.

Alessandro Strada (A)

SCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.

Marina Cretich (M)

SCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.

Alessandro Gori (A)

SCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.

Marina Veronesi (M)

D3-PharmaChemistry, Istituto Italiano di Tecnologia (IIT), Genova, Italy.

Tiziano Bandiera (T)

D3-PharmaChemistry, Istituto Italiano di Tecnologia (IIT), Genova, Italy.

Renzo Vanna (R)

Institute for Photonics and Nanotechnologies, IFN-CNR, c/o Dept. of Physics, Politecnico di Milano, Piazza L. Da Vinci 32, 20133, Milano, Italy.

Gennady Bratslavsky (G)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Stefano A Serapian (SA)

University of Pavia, Department of Chemistry, Viale Taramelli 10, 27100, Pavia, Italy.

Mehdi Mollapour (M)

Department of Urology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Department of Biochemistry and Molecular Biology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.

Giorgio Colombo (G)

SCITEC-CNR, via Mario Bianco 9, 20131, Milano, Italy.
University of Pavia, Department of Chemistry, Viale Taramelli 10, 27100, Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH